RETATRUTIDE - 46 ads

China 401120 Raw materials
Retatrutide

Friday, August 29, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - chongqing
  • +18 0 99 30 10 07
  • +86 19944061337
China 401120 Raw materials
Retatrutide

Wednesday, August 20, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - chongqing
  • +18 0 99 30 10 07
  • +86 19944061337
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday, August 14, 2025

Quantity : 60mg*10via - Price : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 60mg*10via - Price : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 50mg*10via - Price : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 40mg*10via - Price : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 30mg*10via - Price : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 20mg*10via - Price : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 13, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide

Wednesday, August 13, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, August 12, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, August 12, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, August 12, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Saturday, August 09, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Saturday, August 09, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday, August 06, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, August 05, 2025

Quantity : 30mg*10via - Price : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, August 05, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Raw materials
Retatrutide

Friday, August 01, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - chongqing
  • +18 0 99 30 10 07
  • +86 19944061337
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday, July 31, 2025

Quantity : 20mg*10via - Price : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday, July 31, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday, July 31, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday, July 31, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, July 29, 2025

Quantity : 60mg*10via - Price : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, July 29, 2025

Quantity : 50mg*10via - Price : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, July 29, 2025

Quantity : 40mg*10via - Price : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, July 29, 2025

Quantity : 30mg*10via - Price : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, July 29, 2025

Quantity : 20mg*10via - Price : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medical
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday, July 29, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
Number of results per page : 6 30 150

Search RETATRUTIDE


Help on search

  • The search engine doses not care about the case of your text. [ cats dogs ] will search pages talking of cats and dogs in the same page.
  • The double quotes (") allow you to search an exact phrase, respecting all caracters including spaces.
  • The MINUS (-) forbids a word, eg [ dogs -cats ] returns all pages with dogs but no cats inside the text. you can add a MINUS (-) before a sentence with double quotes ("), like -"white cats".